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Background: to describe clinical, radiologic and pathologic features of lung lesions in Birt-
Hogg-Dube` syndrome (BHDS) (MIM 135150).
Method: review of 12 patients of BHDS from 3 unrelated Italian families evaluated at GB Mor-
gagni Hospital, Forlı`, from 2005 to 2010.
Results: mean age (SD) at diagnosis was 44.6 (16) years, 8 (66%) were male. All three index
cases presented with a history of recurrent pneumothorax and/or cystic lung lesions evaluated
by CT scan request by referring pulmonary physicians, none were diagnosed to have BHDS at
the time of initial pulmonary evaluation. One of the three cases was a middle-aged female
patient with a clinical phenotype indistinguishable from lymphangioleiomyomatosis (LAM),
characterized by cystic lung lesions and kidney angiomyolipoma. In one case of BHDS present-
ing with recurrent pneumothorax and a solitary lung nodule, surgical lung resection revealed
a pulmonary histiocytoma. In one case a novel mutation of BHD gene was detected (c.771
del, exon 7).
Conclusions: BHDS is associated with cystic lung disease largely under-recognized by pulmo-
nary physicians and can mimic LAM and may be associated with lung tumor, pulmonary histio-
cytoma. In one case we found a novel mutation in exon 7, c.771 del (ref.seq. NM_144997.5)
never reported before.
ª 2011 Elsevier Ltd. All rights reserved.543 735042; fax: þ39 0453 735039.
gmail.com (V. Poletti).
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Birt-Hogg-Dube` syndrome (BHDS) (MIM 135150) is an auto-
somal dominant genodermatosis, predisposing to the
development of follicular hamartomas of the skin, cystic
lung lesions, pneumothorax and kidney neoplasms. BHDS
was described for the first time in 1977, lung features of
this syndrome have been described only in recent years and
are limited. BHDS is caused by germline mutations in the
BHD (FLCN) gene that is located in the short arm of chro-
mosome 17 (17p11.2) and encodes for folliculin, a tumor
suppressor protein.1 Characteristic skin lesions described in
BHDS are fibrofolliculomas (FF) and trichodiscomas (TD) of
the skin, presenting as small, multiple papules on the face,
neck and upper torso, characterized by strands of prolif-
erating epithelial cells surrounded by a thick layer of
connective tissue.2 Pulmonary cysts are reported in 89% of
affected members of BHDS families, and approximately 24%
of subjects have a history of spontaneous pneumothorax.3
Cystic lung disease in BHDS varies in severity, smoking has
been described to be associated with a more severe lung
disease in one study.4 BHDS is associated with renal tumors
such as chromophobe renal cell carcinoma (33%), hybrid
oncocytic renal cell carcinoma (50%) clear cell renal
carcinoma (9%) or oncocytoma (5%). The association of
kidney angiomyolipoma is unusual in BHD but common in
LAM, a cystic lung disease that shares with BHDS many
features and common pathogenetic mechanisms involving
the m-TOR pathway.5,6 Extra-renal neoplasm such as colo-
rectal adenomas, parotid oncocytomas, parathyroid
adenomas, neural tissue tumors, lipomas, angiolipomas and
connective tissue abnormalities, have been occasionally
observed.7,8 In this study we describe additional pulmonary
features of this under-recognized entity, including the
clinical presentation, radiologic, functional and histopath-
ologic aspects.
Materials and methods
Study population
By referral from pulmonary physicians we evaluated three
index cases and consecutively nine affected family
members from three unrelated BHDS families at the GB
Morgagni Hospital in Forlı` and at the S. Maria Hospital in
Terni e Italy, from January 2005 to June 2010. Molecular
analysis of the BHD gene was performed after patient
informed consent. Ten patients underwent genetic testing
and all were found positive for the heterozygous FLCN
mutation (Table 1). Six cases presented with skin lesions
histological proven FF and one case with a histologically
proven trichodiscoma, all were associated with cystic lung
disease and/or kidney neoplasm and were considered
affected with BHDS. Among the remaining five cases, all
positive for BHDS gene mutation, two cases presented
solely cystic lung lesion on HRTC and three cases did not
show any clinical features of the disease. Histologically an
FF was characterized according to previously published
criteria.2 This study was notified to the institutional review
boards of the local ethic committee in accordance to our
national legislation.Clinical data collection
Data collection included demographic data, clinical presen-
tation, laboratory results, radiologic findings, pulmonary
function studies and pathologic analysis. CTscans of the chest
were reviewed by two Radiologists (A.C. and N.S.). All 12
affected members had both high-resolution and standard CT
scans of the chest available. All tissue specimens, including
seven skin biopsies, one kidney resection, one surgical lung
biopsy and one surgical lung resection, were reviewed by
a lung pathologist (M.C.). Pulmonary function measurements
included plethysmographically determined total lung
capacity, residual volume and diffusing capacity for carbon
monoxidewereperformed in seven cases. Pulmonary function
data were expressed as percentage of predicted normal
values. Additional information was obtained from patients
interview and outside medical records review.
Mutation analysis
Genotype profile of family members was evaluated by
mutation analysis. DNA extraction and mutation analysis of
BHD gene were performed at Ospedale S. Croce e Carle,
Cuneo e Italy. Genomic DNA was extracted and analyzed as
previously reported by our group.9 Genetic profile of the
cases here presented (Table 1, family # 1 and family # 2) have
already been discussed in our previously published paper.9 In
one case (Table 1, family # 3) we found a novel mutation in
exon 7, c.771 del (ref.seq. NM_144997.5) never reported
before and confirmed to be a mutation instead a poly-
morphism on 100 health donors. This is a frameshiftmutation
causing premature stop at protein level (p.Phe258LeufsX5).
Results
Clinical characteristics
Three index cases were referred to our institution, two for
a history of recurrent pneumothorax and one for cystic lung
disease. One of them was a 57 female patient with
a unilateral kidney angiomyolipoma diagnosed by abdomen
CT, suspected to be a case of pulmonary lymphangioleio-
myomatosis (LAM). All three cases had cystic lung lesions
documented by HRTC, none of them had a diagnosis of
BHDS at the time of the initial evaluation by referring
pulmonary physicians. At the time of evaluation at our
center we documented skin lesions in seven cases, renal
mass in two patients, cystic lung lesions in nine patients.
Mean age (SD) at diagnosis was 44.6 years (16), and 8
(66%) were male. Histological examination of skin lesions
confirmed six fibrofolliculomas and one trichodiscoma. Two
patients were current smokers (mean, 11 pack-years) and
two were former smokers (mean, 20 pack-years). None of
them had a significant environmental exposure. Four
patients (age range, 47e57 years) reported a history of
recurrent pneumothorax (between 1 and 3 pneumothoraces
per patient), two were former smokers. All cases of
recurrent pneumothorax were treated with pleurodesis.
Two patients were symptomatic and reported mild exer-
tional dyspnea and cough, one was a never smoker patient
with innumerable bilateral cysts and normal PFTs (Table 1,
Table 1 Clinical and CT findings.
Geder/age FLNC gene mutation Smoking Clinical presentation CT of the chest Pulmonary function
Family # 1
F/57 INDEX CASE ND Never Fibrofolliculomas of the face and neck.
Recurrent pneumothorax. Bilateral pulmonary
cysts monolateral renal angiomyolipoma.
Innumerable bilateral
cysts.
ND
M/50 c.1127 G > A exon 10 Former,
pack-yr 20
Fibrofolliculomas of the face and neck.
Recurrent pneumothorax. Bilateral pulmonary
cysts on HRCT. Pulmonary nodule 12 mm
(hystiocytoma). No renal tumor.
2 to 7 cysts (8e16 mm
in diameter) in
each lung
Normal
M/52 c.1127 G > A exon 10 Former,
pack-yr 20
Fibrofolliculomas of the face and neck.
Recurrent pneumothorax. Bilateral pulmonary
cysts on HRCT. Kidney cancer involving the
renal vein (mixed chromophobe, clear cell and
oncocytic).
3 to 6 cysts (5e31 mm
in diameter) in
each lung (Fig. 2)
ND
M/37 c.1127 G > A exon 10 Never No skin lesions. No respiratory symptoms. No
renal tumor.
Normal ND
F/31 c.1127 G > A exon 10 Never No skin lesions. No respiratory symptoms. No
renal tumor.
Normal ND
F/85 ND Never Fibrofolliculomas of the face and neck.
Dyspnea. Bilateral pulmonary cysts and
emphysema on HRCT. No renal tumor.
Innumerable bilateral
cysts and emphysema
ND
Family # 2
F/47 INDEX CASE c.1492C > T exon 12 Never Fibrofolliculomas of the face. Bilateral
pneumothorax. Bilateral pulmonary cysts on
HRCT. No renal lesions.
Innumerable bilateral
cysts (4e57 mm in
diameter)
Normal PFTs.Mild
reduction of
DLco 62%pred.
M/42 c.1492C > T exon 12 Never No respiratory symptoms. No skin lesions. No
renal tumor. Bilateral pulmonary cysts on
HRCT.
6 to 9 cysts (4e26 mm
in diameter) in
each lung
Normal
M/44 c.1492C > T exon 12 Current,
pack-yr 20
Trichodiscomas of the face. No respiratory
symptoms. Bilateral pulmonary cysts on HRCT.
No renal tumor.
4 cysts (43e13 mm in
diameter) in each lung
Normal
M/20 c.1492C > T exon 12 Current,
pack-yr 2,5
No respiratory symptoms. No skin lesions. No
renal tumor.
Normal Normal
M/24 c.1492C > T exon 12 Never No respiratory symptoms. Bilateral pulmonary
cysts on HRCT. No skin lesions. No renal tumor.
4 to 7 cysts (3e8 mm
in diameter) in
each lung (Fig. 2)
Normal
Family # 3
M/47 c.771 del exon 7 Never Cough. Bilateral pulmonary cysts on HRCT.
Fibrofolliculomas of the face. No renal lesions.
Innumerable bilateral
cysts (5e30 mm in
diameter) in each lung.
Mild restriction and mild
reduction in DLco
(TLC 62%; DLco 60%).
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Figure 1 The morphologic and immunophenotypic characterization of 12 mm solitary lung nodule in the left lower lobe A-B)
Hematoxylin e Eosin: morphologic features were consistent with pulmonary histiocytoma; C-D) Cathepsin e k was strongly
expressed, E) CD16 was positive; F) CK8 was negative.
Pulmonary features of Birt-Hogg-Dube´ syndrome 771case M/47) and the other one was a 85 year-old female non
smoker with cystic lung disease and emphysema.
Indication for CTscanwas recurrent pneumothorax in two
index cases, persistent cough in one index case and screening
for BHDS in all other cases evaluated at our institution. Cystic
lung lesions were detectable on high-resolution CT scan of
the thorax in nine patients (75%), age ranging from 24 to 85
years. The cysts were variably demarcated by a thin-wall
which ranged from invisible to nearly 2 mm thick, round or
oval in shape with a surrounding normal parenchyma; they
were scattered throughout the lungs with a slightly higher
frequencies in the lower zones, the size of the cysts tending
to be larger in the lower lobes, rangingbetween 3 and 57mm.
Lung cysts in patients presenting with bilateral pneumo-
thorax were significantly more profuse and larger than those
of other family members.
Pulmonary function tests were performed in seven
patients and one patient had mild restriction (total lung
capacity 62% of predicted value) with a mild reduction of
DLco in two patients (DLco 62% and 60% of predicted value)
(Table 1).
Surgical lung biopsy specimens were available in two
patients who underwent pleurodesis and subsegmental lung
resection (Table 1, case F/47 and case M/50). Histologic
sections showed pulmonary cysts characterized by cystic
dilatation of alveolar spaces ranging from microscopic foci
to a few millimeters in diameter. The thin walled cysts
were lined by cuboidal epithelium with no fibrous or smooth
muscle tissue in the wall.
One patient underwent a surgical lung resection for
a pulmonary solitary nodule measuring 12 mm in the left
lower lobe. The morphologic and immunophenotypic char-
acterization of this lesion were consistent with diagnosis of
histiocytoma. Immunohistochemical staining with TTF1,HMB45, S-100, KERATIN 8, 18 and19, CD1a and CD208 were
all negative. CD16, CD68 were positive and cathepsin-K was
strongly expressed (Fig. 1). The surrounding lung paren-
chyma and lung cysts were negative for cathepsin-k
expression. Histological review of the only case (Table 1,
case M/52) of kidney neoplasm (right kidney, 3 cm of
diameter with renal vein involvement) revealed a mixed
pattern of clear cell, cromophobe and oncocytic renal
cancer, with no expression of Cathepsin-K.Discussion
This study reports 12 cases of BHDS, nine (75%) of whom
presented with characteristic cystic lung lesions and four
(33%) with a history of recurrent pneumothorax. Cystic lung
lesions associated with BHD syndrome can appear at varying
ages, in this case series ranging between 20 and 85 years.
Severity of cystic lung disease appeared related to age but
not to smoking history. Recent reports have well described
radiologic and clinical features of cystic lung disease in
BHDS and failed to document a possible relation between
the severity of cystic lung disease and smoking history,3
that is in accordance with our data. Most patients were
asymptomatic, older patients and those with more severe
lung involvement, tended to be more likely to have symp-
toms, particularly dyspnea, cough and recurrent pneumo-
thorax. Pulmonary function was normal in most cases and
only mildly impaired in two cases.
BHDS has become more recognized in recent years, but
awareness of pulmonary physicians is still low. In the present
study none of three index cases evaluatedwith CTscan prior to
referral to our centerwas suspected to have BHDS. Differential
diagnosis for cystic lung disease of BHDS has been discussed in
Figure 2 The high-resolution CT scan of two cases of BHDS. CT scan of upper lobes (A) and lower lobes (B) of the patient M/24,
family #2. This case is representative of an early case of BHDS. Cysts were variably demarcated by a thin-wall and surrounded by
normal parenchyma. Cysts were 4 in right lung and 7 in the left lung with diameter ranging from 3 to 8 mm. (C) CT scan of case
M/52, family #1. This patient had a history of recurrent bilateral pneumothorax. The HRCT documented 3 to 6 cysts (5e31 mm in
diameter) in each lung.
772 S. Tomassetti et al.previous studies3,4,14,15 and include pulmonary LAM, pulmo-
nary Langerhans cell histiocytosis, Pneumocystis pneumonia,
lymphocytic interstitial pneumonia and metastatic neoplasms
including adenocarcinomas and low-grade sarcomas.In particular, distinguishing BHDS from LAM can be very
difficult. In the present report we describe a case of a 57
year-old woman presenting with FF of the face and a history
of recurrent pneumothoraces. The CT scan documented
Pulmonary features of Birt-Hogg-Dube´ syndrome 773cystic lung lesions and a unilateral angiomyolipoma of the
kidney. FF has been considered to be clinically character-
istic of BHDS, but a recent report described FF of the skin in
a patient with tuberous sclerosis complex (TSC). Therefore,
the presence of FF is a useful but not a sufficient clinical
element in the diagnosis of BHDS.10,11 The renal angio-
myolipoma is a type of kidney tumor that has never been
observed in BHDS and is characteristically associated with
sporadic LAM or tuberous sclerosis complex (TSC). This
lesion represents another previously unreported overlap in
clinical features between LAM and BHDS. The patient
denied her consent for genetic testing and the final diag-
nosis of BHDS in this patient was based on family history of
BHDS: four siblings (Table 1) were affected and positive for
BHD gene mutation (c.1127 G > A mutation, exon 10). To
exclude the presence of TSC one brother (Table 1, case
M/50) was tested for both BHDS gene mutation and TSC1
and 2 and was found positive only for BHDS.
Clinical similarities between BHDS and TSC have
induced a search for a common molecular pathogenesis
for BHD and TSC and have led to the discovery that both
BHD and TSC1/TSC2 are tumor suppressor genes that
function through the common pathway of target of rapa-
mycin proteins (m-TOR), associated with renal tumori-
genesis. Kidney tumors are present in one third of
patients with BHDS, are often multiple, and can present
different histologic types, including oncocytome, choro-
mophobe carcinoma, renal cell carcinoma and hybrid
oncocytic/chromophobe carcinoma. Other neoplastic
lesions of BHDS include intestinal colorectal adenomas,
parotid oncocytomas, parathyroid adenomas, and neural
tissue tumors.7,8
Association between lung tumor and BHDS has never
been previously reported. Herein, we describe a case of
pulmonary histiocytoma in a 50 year-old male, former
smoker (PY 20), presenting with fibrofolliculomas of the
face and neck, a history of recurrent pneumothorax and
cystic lung lesions (Table 1, case M/50). The patient
underwent surgical lung resection of a left basal solitary
lung nodule of 12 mm. Pathologic analysis documented
a pulmonary histiocytoma in the context of lung paren-
chyma disseminated with cystic lesions characterized by
enlargement of alveolar spaces lined by cuboidal epithe-
lium with no fibrous or smooth muscle tissue in the wall.
Histiocytoma is a tumor composed of true histiocytes. It
belongs to the large and controversial family of fibrohis-
tiocytic tumors characterized by a dual cellular composi-
tion: cell with a fibroblastic appearance mixed with other
cells having histiocytic features. Fibrohistiocytic tumors in
the lung can present with bilateral cystic lesions or thin
walled cavities causing hemoptysis, dyspnea or pneumo-
thorax.12 In the present case, histologic features of lung
cysts were found to be consistent with the typical cystic
lesions of BHDS and the research of spindle cells underlying
the cystic wall was negative. This allowed a clear distinc-
tion from cystic fibrohistiocytic tumor. The lung nodule
here reported presented the classical immunohistochem-
ical profile and morphologic characteristics of histiocy-
toma. Interestingly cathepsin-K was strongly expressed in
both spindle and epithelioid-shaped cells of the histiocy-
toma, but negative both in the normal parenchyma and in
the cystic lesions. Lesions with a strong expression of thismarker have never been described in BHDS. Given that
cathepsin-K is known to be highly expressed in LAM13
(particularly in the pulmonary foci of LAM cells and in
renal angiomyolipoma cells) and that the m-TOR pathway
regulates cathepsin-K expression, it is possible to speculate
that also in BHDS the genetic mutation causing deregulation
in m-TOR pathway leads to the production of cathepsin-K
by spindle cells in the pulmonary histiocytoma here
described. However, the complete lack of cathepsin-K
expression documented in both lung cysts of this BHDS case
and the kidney neoplasm of one brother (Table 1, case
M/52) militates against this hypothesis. This is the first
report of a true histiocytoma in the lung of a patient
affected by BHDS. Whether there is or not a correlation
between the BHD gene mutation and the development of
this lesion remains to be addressed. This family, presenting
with two peculiar cases among the six affected members,
carries a novel mutation involving exon 10, whether this
peculiar clinical phenotype is related to this novel mutation
remains to be clarified.
The two main limitations of this study are that it
is retrospective and conducted on a small number of
patients.
It appears that cystic lung disease in BHDS may vary in
severity and is mainly affected by age in accordance with
previous studies.3,14,15 The identification of early cases
(Fig. 2) and the differential diagnosis from other cystic lung
disorders is still problematic. The collection of an accurate
family history and performing genetic investigations are
two key steps in reaching a differential diagnosis with other
diffuse cystic lung disorders that can mimic BHDS (partic-
ularly LAM and TSC). Lung tumor in BHDS has never been
previously reported and further studies are needed to
clarify whether the pulmonary histiocytoma here described
could be linked to this rare disease or if it is just an inci-
dental finding.
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